Tavneos

Active Ingredient(s): Avacopan
FDA Approved: * October 7, 2021
Pharm Company: * CHEMOCENTRYX

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Tavneos Overview

Avacopan, sold under the brand name Tavneos, is a medication used to treat anti-neutrophil cytoplasmic autoantibody-associated vasculitis.[1][3] Avacopan was approved for medical use in Japan in September 2021,[2] and in the United States in October 2021.[1][3] It is the first orally-administered inhibitor of the complement C5a receptor approved by the U.S. Food and Drug Administration (FDA).[3] C...

Read more Tavneos Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Avacopan

Recent Tavneos Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Avacopan
  • Capsule: 10mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Avacopan or a similar ingredient: (1 result)